Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 206

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Brain-Targeted Proanthocyanidin Metabolites for Alzheimer's Disease Treatment

Open access
Wang, Jun, Ferruzzi, Mario G., Ho, Lap, Blount, Jack, Janle, Elsa M., Gong, Bing, Pan, Yong, Gowda, G. A. Nagana, Raftery, Daniel, Arrieta-Cruz, Isabel, Sharma, Vaishali, Cooper, Bruce, Lobo, Jessica, Simon, James E., Zhang, Chungfen, Cheng, Alice, Qian, Xianjuan, Ono, Kenjiro, Teplow, David B., Pavlides, Constantine, Dixon, Richard A., Pasinetti, Giulio M.·2012·The Journal of Neuroscience

Abstract

While polyphenolic compounds have many health benefits, the potential development of polyphenols for the prevention/treatment of neurological disorders is largely hindered by their complexity as well as by limited knowledge regarding their bioavailability, metabolism, and bioactivity, especially in the brain. We recently demonstrated that dietary supplementation with a specific grape-derived polyphenolic preparation (GP) significantly improves cognitive function in a mouse model of Alzheimer's disease (AD). GP is comprised of the proanthocyanidin (PAC) catechin and epicatechin in monomeric (Mo), oligomeric, and polymeric forms. In this study, we report that following oral administration of the independent GP forms, only Mo is able to improve cognitive function and only Mo metabolites can selectively reach and accumulate in the brain at a concentration of ∼400 n m. Most importantly, we report for the first time that a biosynthetic epicatechin metabolite, 3′-O-methyl-epicatechin-5-O-β-glucuronide (3′-O-Me-EC-Gluc), one of the PAC metabolites identified in the brain following Mo treatment, promotes basal synaptic transmission and long-term potentiation at physiologically relevant concentrations in hippocampus slices through mechanisms associated with cAMP response element binding protein (CREB) signaling. Our studies suggest that select brain-targeted PAC metabolites benefit cognition by improving synaptic plasticity in the brain, and provide impetus to develop 3′-O-Me-EC-Gluc and other brain-targeted PAC metabolites to promote learning and memory in AD and other forms of dementia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.6437-11.2012

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 206

Metadata

Authors
Wang, J., Ferruzzi, M. G., Ho, L., Blount, J., Janle, E. M., Gong, B., Pan, Y., Gowda, G. A. N., Raftery, D., Arrieta-Cruz, I., Sharma, V., Cooper, B., Lobo, J., Simon, J. E., Zhang, C., Cheng, A., Qian, X., Ono, K., Teplow, D. B., Pavlides, C., Dixon, R. A., & Pasinetti, G. M.
Venue
The Journal of Neuroscience
Published
2012-04-11
Volume
32
Issue
15
Pages
5144-5150
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2016977901
Cited by
206
References
5
FWCI
10.94
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain-Targeted Proanthocyanidin Metabolites for Alzheimer's Disease Treatment. https://app.cochat.ai/papers/10.1523/jneurosci.6437-11.2012
The paper
Wang, J., Ferruzzi, M. G., Ho, L., Blount, J., Janle, E. M., Gong, B., Pan, Y., Gowda, G. A. N., Raftery, D., Arrieta-Cruz, I., Sharma, V., Cooper, B., Lobo, J., Simon, J. E., Zhang, C., Cheng, A., Qian, X., Ono, K., Teplow, D. B., . . . Pasinetti, G. M. (2012). Brain-Targeted Proanthocyanidin Metabolites for Alzheimer's Disease Treatment. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.6437-11.2012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.